Akebia Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKBA and other ETFs, options, and stocks.

About AKBA

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. 

CEO
John P. Butler
CEOJohn P. Butler
Employees
426
Employees426
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2007
Founded2007
Employees
426
Employees426

AKBA Key Statistics

Market cap
59.73M
Market cap59.73M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.41M
Average volume1.41M
High today
$0.3299
High today$0.3299
Low today
$0.305
Low today$0.305
Open price
$0.31
Open price$0.31
Volume
1.02M
Volume1.02M
52 Week high
$3.35
52 Week high$3.35
52 Week low
$0.30
52 Week low$0.30

AKBA Earnings

-$0.51
-$0.26
-$0.02
$0.23
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, Pre-Market
ActualExpected Nov 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.